Similarly, the mRNA expression levels of granzyme A, B and M were downregulated in PBMCs from lung cancer patients, supporting a reduced cytotoxic capacity of peripheral blood cells in the context of cancer (47–49). Here, GZMA is linked to lung carcinoma.